Kyle M. Devins

Mutational spectrum in clinically aggressive low-grade serous carcinoma/serous borderline tumors of the ovary-Clinical significance of BRCA2 gene variants in genomically stable tumors.

R. Drapkin, E. Ko, F. Simpkins, 2021, Gynecologic oncology.

L1CAM is required for early dissemination of fallopian tube carcinoma precursors to the ovary

G. Mills, P. Altevogt, P. Kroeger, 2022, Communications biology.

Fallopian tube precursor lesions of serous ovarian carcinoma require L1CAM for dissemination and metastasis

G. Mills, P. Altevogt, R. Drapkin, 2018, bioRxiv.

CCNE1 copy number is a biomarker for response to combination WEE1-ATR inhibition in ovarian and endometrial cancer models

G. Mills, K. Nathanson, R. Drapkin, 2021, Cell reports. Medicine.

Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models

G. Mills, R. Scharpf, V. Velculescu, 2020, Nature Communications.